The Combined Use of SCD Probiotics and Tauroursodeoksikolik Asit (TUDCA) is More Effective in Controlling Anxiety-Like Behavior in Aged Rats

Abstract

In this study, the effects of TUDCA administration with a SCD probiotics for one week on locomotors activity and anxious behavior were investigated. Male Saprague-Dawley rats aged 24 months were used as the model organism. At the end of the application, open-field and elevated plus maze behavioral tests were performed on the rats. Although SCD probiotics were more effective on anxious behavior, the group in which they were administered together had a significantly greater effect on locomotor activity and anxious behavior. This study provides important evidence that combining SCD probiotics and TUDCA administration may be more beneficial to behavior.

Keywords

• TUDCA
• SCD probiotics
• OF
• EPM
• Anxiety.

References

1. [1] J. F. Cryan and T. G. Dinan, “Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour,” Nat. Rev. Neurosci., vol. 13, no. 10, pp. 701–712, 2012.
2. [2] C. R. Martin and E. A. Mayer, “Gut-brain axis and behavior,” Nestle Nutr. Inst. Workshop Ser., vol. 88, pp. 45–53, 2017.
3. [3] G. Stavrou and K. Kotzampassi, “Gut microbiome, surgical complications and probiotics,” Ann. Gastroenterol., vol. 30, no. 1, pp. 45–53, 2017.
4. [4] R. George Kerry, J. K. Patra, S. Gouda, Y. Park, H.-S. Shin, and G. Das, “Benefaction of probiotics for human health: A review,” J. Food Drug Anal., vol. 26, no. 3, pp. 927–939, 2018.
5. [5] K. M. Maslowski and C. R. Mackay, “Diet, gut microbiota and immune responses,” Nat. Immunol., vol. 12, no. 1, pp. 5–9, 2011.
6. [6] Z. Song et al., “Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome,” Microbiome, vol. 7, no. 1, p. 9, 2019.
7. [7] P. Gérard, “Metabolism of cholesterol and bile acids by the gut Microbiota,” Pathogens, vol. 3, no. 1, pp. 14–24, 2013.
8. [8] M. L. Chen, K. Takeda, and M. S. Sundrud, “Emerging roles of bile acids in mucosal immunity and inflammation,” Mucosal Immunol., vol. 12, no. 4, pp. 851–861, 2019.

9. [9] S. L. Long, C. G. M. Gahan, and S. A. Joyce, “Interactions between gut bacteria and bile in health and disease,” Mol. Aspects Med., vol. 56, pp. 54–65, 2017.
10. [10] J. A. Winston and C. M. Theriot, “Diversification of host bile acids by members of the gut microbiota,” Gut Microbes, vol. 11, no. 2, pp. 158–171, 2020.
11. [11] E. A. Franzosa et al., “Gut microbiome structure and metabolic activity in inflammatory bowel disease,” Nat. Microbiol., vol. 4, no. 2, pp. 293–305, 2019.
12. [12] Q. Lu, Z. Jiang, Q. Wang, H. Hu, and G. Zhao, “The effect of Tauroursodeoxycholic acid (TUDCA) and gut microbiota on murine gallbladder stone formation,” Ann. Hepatol., vol. 23, no. 100289, p. 100289, 2021.
13. [13] X. Wu et al., “Protective effects of tauroursodeoxycholic acid on lipopolysaccharide-induced cognitive impairment and neurotoxicity in mice,” Int. Immunopharmacol., vol. 72, pp. 166–175, 2019.
14. [14] M. Song et al., “Tauroursodeoxycholic acid (TUDCA) improves intestinal barrier function associated with TGR5-MLCK pathway and the alteration of serum metabolites and gut bacteria in weaned piglets,” J. Anim. Sci. Biotechnol., vol. 13, no. 1, p. 73, 2022.
15. [15] X. Zheng, S. Wang, and W. Jia, “Calorie restriction and its impact on gut microbial composition and global metabolism,” Front. Med., vol. 12, no. 6, pp. 634–644, 2018.
16. [16] T. Ceylani, E. Jakubowska-Doğru, R. Gurbanov, H. T. Teker, and A. G. Gozen, “The effects of repeated antibiotic administration to juvenile BALB/c mice on the microbiota status and animal behavior at the adult age,” Heliyon, vol. 4, no. 6, p. e00644, 2018.
17. [17] J. M. Castellano, “Blood-based therapies to combat aging,” Gerontology, vol. 65, no. 1, pp. 84–89, 2019.
18. [18] E. D. Nolte, K. A. Nolte, and S. S. Yan, “Anxiety and task performance changes in an aging mouse model,” Biochem. Biophys. Res. Commun., vol. 514, no. 1, pp. 246–251, 2019.
19. [19] C.-S. Kim et al., “Probiotic supplementation improves cognitive function and mood with changes in gut Microbiota in community-dwelling older adults: A randomized, double-blind, placebo-controlled, multicenter trial,” J. Gerontol. A Biol. Sci. Med. Sci., vol. 76, no. 1, pp. 32–40, 2021.
20. [20] P. Sengupta, “The laboratory rat: Relating its age with human’s,” Int. J. Prev. Med., vol. 4, no. 6, pp. 624–630, 2013.
21. [21] A. A. Walf and C. A. Frye, “The use of the elevated plus maze as an assay of anxiety-related behavior in rodents,” Nat. Protoc., vol. 2, no. 2, pp. 322–328, 2007.
22. [22] M. Komada, K. Takao, and T. Miyakawa, “Elevated plus maze for mice,” J. Vis. Exp., no. 22, 2008.
23. [23] T. Eom, Y. S. Kim, C. H. Choi, M. J. Sadowsky, and T. Unno, “Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease,” J. Microbiol., vol. 56, no. 3, pp. 189–198, 2018.
24. [24] Z. Chen et al., “Bacillus subtilis promotes the release of 5-HT to regulate intestinal peristalsis in STC mice via bile acid and its receptor TGR5 pathway,” Dig. Dis. Sci., vol. 67, no. 9, pp. 4410–4421, 2022.
25. [25] K. Leung and S. Thuret, “Gut Microbiota: A modulator of brain plasticity and cognitive function in ageing,” Healthcare (Basel), vol. 3, no. 4, pp. 898–916, 2015.
26. [26] Y.-W. Liu et al., “Psychotropic effects of Lactobacillus plantarum PS128 in early life-stressed and naïve adult mice,” Brain Res., vol. 1631, pp. 1–12, 2016.
27. [27] A. V. Rao et al., “A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome,” Gut Pathog., vol. 1, no. 1, p. 6, 2009.
28. [28] T. Wang et al., “Lactobacillus fermentum NS9 restores the antibiotic induced physiological and psychological abnormalities in rats,” Benef. Microbes, vol. 6, no. 5, pp. 707–717, 2015.